Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells

Curative management of pancreatic adenocarcinoma is limited because this malignancy remains resistant to most chemotherapeutic drugs. Strategies that reverse epigenetic alterations offer a unique opportunity for cancer cell reprogramming, which is valuable for development of new treatments. The aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Gailhouste, Luc, Liew, Lee Chuen, Hatada, Izuho, Nakagama, Hitoshi, Ochiya, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920091/
https://www.ncbi.nlm.nih.gov/pubmed/29700299
http://dx.doi.org/10.1038/s41419-018-0487-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920091/
https://www.ncbi.nlm.nih.gov/pubmed/29700299
http://dx.doi.org/10.1038/s41419-018-0487-z

Ejemplares similares